1 citations,
July 2021 in “Anais Brasileiros de Dermatologia” The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.
1 citations,
January 2021 in “Skin appendage disorders” Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.
1 citations,
December 2020 in “Harran Üniversitesi týp fakültesi dergisi” Many people with hair loss had low iron and ferritin levels.
1 citations,
January 2020 in “Indian Dermatology Online Journal” Pigtail hair is a sign of new hair growth and should be recognized in hair loss conditions like acute telogen effluvium.
1 citations,
January 2018 in “Turkiye Klinikleri Journal of Dermatology” Vitamin D levels are not correlated with chronic hair loss in Telogen Effluvium patients.
1 citations,
January 2018 in “Annals of medical research” No link found between blood groups, Rhesus factor, and ferritin levels in women with hair loss.
1 citations,
January 2017 in “Yonsei Medical Journal” Hair is thinner near the scalp in acute hair shedding conditions.
1 citations,
September 2011 in “UHOD : Uluslararası hematoloji - onkoloji dergisi” Looking at tissue characteristics isn't reliable for telling apart basal cell carcinoma from certain benign skin tumors.
1 citations,
January 2009 in “Journal of Clinical Dermatology” Hair loss after childbirth is more common in women who have had multiple births, cesarean deliveries, significant weight gain, and full-term pregnancies.
November 2024 in “SKIN The Journal of Cutaneous Medicine” The gummy improved hair growth and reduced shedding in women.
November 2024 in “Skin Appendage Disorders” Telogen effluvium most affects quality of life in alopecia patients.
September 2024 in “Journal of Health and Rehabilitation Research” COVID-19 is linked to temporary hair loss, especially in women.
September 2024 in “Clinical and Experimental Dermatology” COVID-19 increased hair loss cases, but vaccination did not.
Blood cell counts could help predict and treat alopecia areata and telogen effluvium.
July 2024 in “Brazilian Journal of Clinical Medicine and Review” Hair loss after bariatric surgery is common due to nutrient deficiencies and rapid weight loss.
June 2024 in “Archives of dermatological research” Targeted testing for telogen effluvium patients can save healthcare costs.
Post-COVID-19 hair loss is not linked to vitamin D or quality of life but is linked to hair graying.
May 2024 in “Our Dermatology Online” Excessive hair loss can be an early sign of celiac disease.
April 2024 in “Benha Medical Journal” H. pylori infection may be linked to the hair shedding condition Telogen Effluvium.
Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.
January 2024 in “İstanbul Kuzey Klinikleri” Low ferritin levels are linked to increased hair loss; no link found between vitamin B12, TSH levels, and hair loss.
October 2023 in “The Journal of Dermatology” The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.
September 2023 in “Brazilian Journal of Health Review” COVID-19 may cause a common type of hair loss called telogen effluvium.
COVID-19 infection is highly related to increased hair loss, especially in women.
July 2023 in “Zenodo (CERN European Organization for Nuclear Research)” COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.
July 2023 in “Dermatology practical & conceptual” Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.
July 2023 in “Regenerative Therapy” Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.
June 2023 in “Benha Journal of Applied Sciences” People with chronic hair shedding have lower antioxidant levels in their blood compared to healthy individuals.
June 2023 in “Journal of personalized medicine” Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.
May 2023 in “Journal of contemporary medicine” Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.